Developed in partnership with the Our Partner
In "Beyond Diagnosis: Alzheimer's Disease," Cleveland Clinic behavioral neurologist Jagan Pillai, MD, PhD, and host Glenn Campbell continue their discussion on communicating effectively with patients and families facing a progressive neurodegenerative illness.
Each monthly installment examines an aspect of Alzheimer's disease care, including diagnosis, prognosis, treatment decisions, and ongoing support for patients and caregivers.
This fifth of six episodes focuses on the future of Alzheimer's care, including clinical trial participation, emerging combination therapies, and how advances in biomarkers may shape earlier diagnosis and treatment.
The following is a transcript of their remarks:
